Nicholas LaRocca
Overview
Explore the profile of Nicholas LaRocca including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
15
Citations
931
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Braley T, Ehde D, Alschuler K, Little R, Ng Y, Zhai Y, et al.
Lancet Neurol
. 2024 Oct;
23(11):1108-1118.
PMID: 39424559
Background: Fatigue is one of the most disabling symptoms reported by people with multiple sclerosis. Although behavioural and pharmacological interventions might be partly beneficial, their combined effects have not been...
2.
Bebo B, Cintina I, LaRocca N, Ritter L, Talente B, Hartung D, et al.
Neurology
. 2022 Apr;
98(18):e1810-e1817.
PMID: 35418457
Background And Objectives: A recent report estimated that approximately 1 million adults were living with multiple sclerosis (MS) in the United States. Although MS is rarely the direct cause of...
3.
Li J, Bishop M, Fraser R, Rumrill P, LaRocca N, Burns M, et al.
Work
. 2022 Mar;
71(4):987-1005.
PMID: 35253664
Background: The National Multiple Sclerosis Society (NMSS) strives to ensure that people affected by multiple sclerosis (MS) can live their best lives. This mission is reflected in the Society's strategic...
4.
Motl R, Ehde D, Shinto L, Fernhall B, LaRocca N, Zackowski K
Arch Phys Med Rehabil
. 2020 Sep;
101(10):1839-1841.
PMID: 32868038
No abstract available.
5.
Gasper J, Lewis M, Kroeger A, Muz B, LaRocca N, Frankel D
Int J MS Care
. 2020 Sep;
22(4):187-192.
PMID: 32863787
Background: Multiple sclerosis adult day programs (MSADPs) offer life-enhancing services for individuals and informal caregivers affected by multiple sclerosis (MS), including medical care, rehabilitation therapies, nutrition therapy, cognitive training, tailored...
6.
Tallantyre E, Evangelou N, Bale C, Chaudhry B, Gray E, LaRocca N, et al.
Neurol Clin Pract
. 2020 Jul;
10(3):265-272.
PMID: 32642328
There is a growing need for patient and public involvement (PPI) to inform the way that research is developed and performed. International randomized controlled trials are particularly likely to benefit...
7.
Buka S, Wallin M, Culpepper W, Lee Y, Marrie R, Nelson L, et al.
Neuroepidemiology
. 2020 Jan;
54(2):123-130.
PMID: 31991409
Background: Multiple sclerosis (MS) is the most common chronic neurologic disease of young adults, placing a heavy burden on patients, families, and the healthcare system. Ongoing surveillance of the incidence...
8.
Fitzgerald K, Sand I, Senders A, Spain R, Giesser B, Sullivan P, et al.
Mult Scler Relat Disord
. 2019 Nov;
37:101478.
PMID: 31704546
Disease course in people with multiple sclerosis (MS) is heterogeneous. The impact of dietary and nutritional factors on MS prognosis is of interest to both patients and clinicians; differences in...
9.
Kalb R, Beier M, Benedict R, Charvet L, Costello K, Feinstein A, et al.
Mult Scler
. 2018 Oct;
24(13):1665-1680.
PMID: 30303036
Purpose: To promote understanding of cognitive impairment in multiple sclerosis (MS), recommend optimal screening, monitoring, and treatment strategies, and address barriers to optimal management. Methods: The National MS Society ("Society")...
10.
Wahls T, Scott M, Alshare Z, Rubenstein L, Darling W, Carr L, et al.
Trials
. 2018 Jun;
19(1):309.
PMID: 29866196
Background: Fatigue is one of the most disabling symptoms of multiple sclerosis (MS) and contributes to diminishing quality of life. Although currently available interventions have had limited success in relieving...